Bayer Aktiengesellschaft (BAYRY)
OTCMKTS: BAYRY · Delayed Price · USD
6.91
-0.07 (-1.00%)
Jul 2, 2024, 3:55 PM EDT - Market closed

Bayer Aktiengesellschaft Revenue

Bayer Aktiengesellschaft had revenue of 47.01B EUR in the twelve months ending March 31, 2024, down -6.88% year-over-year. Revenue in the quarter ending March 31, 2024 was 13.77B EUR, a -4.34% decrease year-over-year. In the year 2023, Bayer Aktiengesellschaft had annual revenue of 47.64B EUR, a decrease of -6.11%.

Revenue (ttm)
47.01B EUR
Revenue Growth
-6.88%
P/S Ratio
0.54
Revenue / Employee
478,801 EUR
Employees
98,189
Market Cap
27.15B USD

Revenue Chart

* This company reports financials in EUR.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202347.64B-3.10B-6.11%
Dec 31, 202250.74B6.66B15.10%
Dec 31, 202144.08B2.68B6.48%
Dec 31, 202041.40B-2.15B-4.93%
Dec 31, 201943.55B3.96B10.00%
Dec 31, 201839.59B4.57B13.05%
Dec 31, 201735.02B-11.75B-25.13%
Dec 31, 201646.77B445.00M0.96%
Dec 31, 201546.32B4.09B9.67%
Dec 31, 201442.24B2.08B5.18%
Dec 31, 201340.16B397.00M1.00%
Dec 31, 201239.76B3.23B8.85%
Dec 31, 201136.53B1.44B4.10%
Dec 31, 201035.09B3.92B12.58%
Dec 31, 200931.17B-1.75B-5.32%
Dec 31, 200832.92B533.00M1.65%
Dec 31, 200732.39B3.43B11.84%
Dec 31, 200628.96B1.59B5.82%
Dec 31, 200527.36B-2.37B-7.98%
Dec 31, 200429.74B1.22B4.27%
Dec 31, 200328.52B-467.00M-1.61%
Dec 31, 200228.98B-3.30M-0.01%
Dec 31, 200128.99B-573.55M-1.94%
Dec 31, 200029.56B2.24B8.20%
Dec 31, 199927.32B-742.00M-2.64%
Dec 31, 199828.06B--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 379.49B
Johnson & Johnson 81.80B
Merck & Co. 61.40B
AbbVie 54.40B
Novartis AG 49.92B
AstraZeneca 47.61B
Thermo Fisher 42.49B
Abbott Laboratories 40.33B
Revenue Rankings